Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GAR1 ribonucleoprotein homolog pseudogene (ENSG00000249056) is a human pseudogene, meaning it is a genomic sequence similar to the functional GAR1 gene but does not encode a functional protein[4][1]. The functional gene—GAR1—plays a key role in the assembly of H/ACA small nucleolar ribonucleoproteins and the formation of pseudouridine in rRNA[4][5][6]. The pseudogene variant is not translated into protein and does not possess known biological, therapeutic, or diagnostic significance. Queries regarding GAR1 ribonucleoprotein as a therapeutic target should refer to the functional GAR1 gene, not this pseudogene.\n\nIf you intended to request information about the **functional GAR1 gene** (not this pseudogene), please clarify; otherwise, note the limitations of pseudogene entries such as ENSG00000249056 for drug discovery or biomedical targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GAR1 ribonucleoprotein homolog pseudogene.